Novozymes, a Danish company that has its North American headquarters in Franklinton, has named a new CEO.
Peder Holk Nielsen, 56, will take over as president and CEO on April 1. Since 2007, Nielsen has been serving as an executive vice president and head of Enzyme Business, the company's unit that identifies markets for its enzymes. He earlier held positions in business development, research and development and sales and marketing.
“Peder Holk Nielsen’s ability to couple market insight and research capabilities is key to deliver innovation and to continue our growth strategy," said Henrik Gürtler, Chairman of the Board at Novozymes, in a statement. "He was a clear first choice in our international search process."
Nielsen replaces Steen Riisgaard, who had led the company for 12 years.
Novozymes, which employs more than 500 people in Franklinton, develops and supplies enzymes - biological molecules that speed up chemical reactions.
The company's global headquarters are in Copenhagen.